|
Instil Bio ، Inc. (TIL) تقييم DCF |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Instil Bio, Inc. (TIL) Bundle
تبحث لتحديد القيمة الجوهرية لـ Instil Bio ، Inc.؟ يدمج حاسبة DCF (TIL) DCF بيانات العالم الحقيقي بميزات تخصيص شاملة ، مما يتيح لك تحسين توقعاتك وتعزيز اختيارات الاستثمار الخاصة بك.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | -100 | 0 | 0 | 0 | -25 | -25 | -25 | -25 | -25 |
| EBITDA | -33.4 | -154.0 | -217.4 | -146.1 | -62.5 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -24194.2 | 100 | 100 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Depreciation | .3 | 2.8 | 6.0 | 4.8 | 3.6 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 185.51 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -33.6 | -156.8 | -223.4 | -150.9 | -66.1 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -24379.71 | 100 | 100 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Total Cash | 241.7 | 454.1 | 260.9 | 150.4 | 113.3 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 3.2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 2299.28 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | 1.2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 855.8 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | 3.5 | 5.6 | 2.4 | 1.2 | .7 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 2532.61 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -50.8 | -57.8 | -84.6 | -20.7 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -36823.19 | 100 | 100 | 100 | 100 | -20 | -20 | -20 | -20 | -20 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -33.8 | -156.8 | -221.3 | -150.9 | -66.1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -85.2 | -205.4 | -303.1 | -167.9 | -63.1 | -.7 | .0 | .0 | .0 | .0 |
| WACC, % | 20.42 | 20.42 | 20.34 | 20.42 | 20.42 | 20.4 | 20.4 | 20.4 | 20.4 | 20.4 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | -8 | |||||||||
| Equity Value | 7 | |||||||||
| Diluted Shares Outstanding, MM | 7 | |||||||||
| Equity Value Per Share | 1.11 |
What You Will Get
- Pre-Filled Financial Model: Instil Bio, Inc.'s (TIL) actual data enables precise DCF valuation.
- Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers.
- Instant Calculations: Automatic updates ensure you see results as you make changes.
- Investor-Ready Template: A refined Excel file designed for professional-grade valuation.
- Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts.
Key Features
- Real-Life TIL Data: Pre-filled with Instil Bio, Inc.'s historical financials and future forecasts.
- Fully Customizable Inputs: Modify revenue growth, profit margins, discount rates, tax implications, and capital investments.
- Dynamic Valuation Model: Instant updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Testing: Develop multiple forecasting scenarios to evaluate various valuation results.
- User-Friendly Design: Intuitive, organized, and suitable for both professionals and newcomers.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Instil Bio data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Instil Bio’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Instil Bio, Inc. (TIL)?
- Designed for Experts: A sophisticated tool utilized by financial analysts, CFOs, and industry consultants.
- Accurate Data: Instil Bio’s historical and projected financials are preloaded for precise calculations.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the process.
Who Should Use Instil Bio, Inc. (TIL)?
- Investors: Gain insights and make informed decisions with our advanced therapeutic solutions.
- Healthcare Professionals: Utilize our innovative treatments to enhance patient care and outcomes.
- Researchers: Access cutting-edge research tools to advance your studies in cell therapy.
- Pharmaceutical Companies: Collaborate with us to explore new opportunities in the biotech field.
- Educators and Students: Leverage our resources to enrich learning in biotechnology and pharmacology courses.
What the Template Contains
- Historical Data: Includes Instil Bio, Inc.'s (TIL) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Instil Bio, Inc.'s (TIL) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Instil Bio, Inc.'s (TIL) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.